TLSA vs TOVX

Tiziana Life Sciences Ltd vs Theriva Biologics, Inc. — Valuation Comparison 2026

TLSA

Pharmaceutical Preparations
Tiziana Life Sciences Ltd
Quality
1.7
out of 10
Value Trap
Price
$1.41
Last close
Models
7/13
Active
VS

TOVX

Pharmaceutical Preparations
Theriva Biologics, Inc.
Quality
4.0
out of 10
Value Trap
37
LOW
Price
$0.28
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType TLSA Fair ValueTLSA Upside TOVX Fair ValueTOVX Upside
Bayesian DCF Intrinsic $0.43 -69.8% $0.23 -18.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.12 -91.7% $0.05 -87.6%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $1.41 +0.3% $0.72 +152.3%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TLSA vs TOVX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TLSA vs TOVX — Which Stock Is More Undervalued?

TOVX scores higher with a 4.0/10 quality rating vs TLSA's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tiziana Life Sciences Ltd (TLSA) and Theriva Biologics, Inc. (TOVX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TLSA currently trades at $1.41 with a QOC of 1.7/10, while TOVX trades at $0.28 with a QOC of 4.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).